Region:Middle East
Author(s):Geetanshi
Product Code:KRAD4020
Pages:95
Published On:December 2025

By Cycle Type:The cycle type segmentation includes Fresh non-donor IVF cycles, Frozen non-donor IVF cycles, Fresh donor IVF cycles, and Frozen donor IVF cycles. Among these, Fresh non-donor IVF cycles dominate the market due to their higher success rates and the preference of patients for immediate results. The increasing number of couples opting for IVF treatments has led to a significant rise in the demand for fresh cycles, as they are often perceived as more effective compared to frozen cycles.

By Procedure:The procedure segmentation encompasses Conventional IVF, ICSI (Intracytoplasmic Sperm Injection), IUI (Intrauterine Insemination), and Others (e.g., assisted hatching, blastocyst transfer). ICSI is the leading procedure in the market, primarily due to its effectiveness in treating male factor infertility. The increasing prevalence of male infertility issues has driven the demand for ICSI, making it a preferred choice among couples undergoing fertility treatments.

The Oman In Vitro Fertilization Market is characterized by a dynamic mix of regional and international players. Leading participants such as Muscat Fertility & Infertility Center, Oman International Hospital – IVF & Fertility Unit, Al Nahda Hospital – Assisted Reproduction Unit, Badr Al Samaa Group of Hospitals – IVF & Fertility Centers, Aster Al Raffah Hospital – Fertility & IVF Clinic, Fakih IVF Fertility Center Muscat, New Life Fertility Center, Muscat, Al Hayat International Hospital – Obstetrics, Gynecology & IVF Services, Muscat Private Hospital – Fertility and Women’s Health Unit, Royal Hospital – Reproductive Medicine & Infertility Unit, Starcare Hospital Muscat – IVF & Fertility Services, Sultan Qaboos University Hospital – Reproductive Medicine Clinic, Khoula Hospital – Obstetrics and Gynecology Department, Adam & Eve Specialized Medical Center – Fertility Clinic, Al Harthy Medical Centre – Obstetrics, Gynecology & Infertility contribute to innovation, geographic expansion, and service delivery in this space.
The future of the Oman IVF market appears promising, driven by increasing demand for fertility treatments and technological advancements. As more couples seek assistance, the expansion of fertility clinics and the introduction of innovative reproductive technologies will likely enhance service availability. Additionally, the growing acceptance of IVF and supportive government policies are expected to create a conducive environment for market growth, fostering partnerships with international IVF centers to improve service quality and accessibility.
| Segment | Sub-Segments |
|---|---|
| By Cycle Type | Fresh non-donor IVF cycles Frozen non-donor IVF cycles Fresh donor IVF cycles Frozen donor IVF cycles |
| By Procedure | Conventional IVF ICSI (Intracytoplasmic Sperm Injection) IUI (Intrauterine Insemination) Others (e.g., assisted hatching, blastocyst transfer) |
| By End-User | Fertility clinics and IVF centers Multispecialty hospitals Maternity and women’s hospitals Others |
| By Patient Type | Male factor infertility Female factor infertility Combined/Unexplained infertility Others |
| By Age Group (Female Partner) | Under 30 years –34 years –39 years years and above |
| By Geographic Distribution | Muscat Governorate Dhofar Governorate (incl. Salalah) Al Batinah Governorate (incl. Sohar) Other governorates |
| By Payer Type | Out-of-pocket self-pay Corporate and employer-funded plans Private health insurance Government and quasi-government schemes |
The Oman In Vitro Fertilization market is valued at approximately USD 55 million, reflecting a steady increase in demand for IVF procedures driven by rising awareness of infertility treatments and advancements in reproductive technologies.